WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. (Q48733781)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. (English)

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

author name string

Hjorth S

1

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

Westlin D

2

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

Bengtsson HJ

3

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

publication date

1 April 1997

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

36

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

4-5

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

461-465

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Identifiers

10.1016/S0028-3908(97)00050-6

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/9225270

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48733781&oldid=1786219539"